Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Specht Stovgaard

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Acta Oncologica (Stockholm, Sweden)|November 24, 2017
Triple negative breast cancer - prognostic role of immune-related factors: a systematic reviewElisabeth Specht Stovgaard, Dorte Nielsen, Estrid Hogdall, et al.
Pathology Research International|June 2, 2012
Cytokeratin on frozen sections of sentinel node may spare breast cancer patients secondary axillary surgeryElisabeth Specht Stovgaard, Tove Filtenborg Tvedskov, Anne Vibeke Lænkholm, et al.
Breast Cancer Research and Treatment|January 11, 2019
PD-L1 expression in breast cancer: expression in subtypes and prognostic significance: a systematic reviewElisabeth Specht Stovgaard, Anne Dyhl-Polk, Anne Roslind, et al.
Cancers|August 12, 2022
Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical TrialElahe Shenasa, Elisabeth Specht Stovgaard, Maj-Britt Jensen, et al.
Ugeskrift for Laeger|April 13, 2026
[Digital pathology]Christian Beltoft Brøchner, Elisabeth Specht Stovgaard, Jacob Secher Ejlertsen, et al.
Cancers|July 2, 2021
Automated Quantification of sTIL Density with H&E-Based Digital Image Analysis Has Prognostic Potential in Triple-Negative Breast CancersJeppe Thagaard, Elisabeth Specht Stovgaard, Line Grove Vognsen, et al.
Breast Cancer Research and Treatment|May 19, 2018
Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional studyMark O'Loughlin, Xavier Andreu, Simonetta Bianchi, et al.
Cancers|September 10, 2021
Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast CancerDarren Kilmartin, Mark O'Loughlin, Xavier Andreu, et al.
Cancers|February 25, 2023
ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its LimitationsBálint Cserni, Darren Kilmartin, Mark O'Loughlin, et al.
NPJ Breast Cancer|May 16, 2020
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working GroupMohamed Amgad, Elisabeth Specht Stovgaard, Eva Balslev, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Acta Oncologica (Stockholm, Sweden)|November 24, 2017
Triple negative breast cancer - prognostic role of immune-related factors: a systematic reviewElisabeth Specht Stovgaard, Dorte Nielsen, Estrid Hogdall, et al.
Pathology Research International|June 2, 2012
Cytokeratin on frozen sections of sentinel node may spare breast cancer patients secondary axillary surgeryElisabeth Specht Stovgaard, Tove Filtenborg Tvedskov, Anne Vibeke Lænkholm, et al.
Breast Cancer Research and Treatment|January 11, 2019
PD-L1 expression in breast cancer: expression in subtypes and prognostic significance: a systematic reviewElisabeth Specht Stovgaard, Anne Dyhl-Polk, Anne Roslind, et al.
Cancers|August 12, 2022
Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical TrialElahe Shenasa, Elisabeth Specht Stovgaard, Maj-Britt Jensen, et al.
Ugeskrift for Laeger|April 13, 2026
[Digital pathology]Christian Beltoft Brøchner, Elisabeth Specht Stovgaard, Jacob Secher Ejlertsen, et al.
Cancers|July 2, 2021
Automated Quantification of sTIL Density with H&E-Based Digital Image Analysis Has Prognostic Potential in Triple-Negative Breast CancersJeppe Thagaard, Elisabeth Specht Stovgaard, Line Grove Vognsen, et al.
Breast Cancer Research and Treatment|May 19, 2018
Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional studyMark O'Loughlin, Xavier Andreu, Simonetta Bianchi, et al.
Cancers|September 10, 2021
Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast CancerDarren Kilmartin, Mark O'Loughlin, Xavier Andreu, et al.
Cancers|February 25, 2023
ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its LimitationsBálint Cserni, Darren Kilmartin, Mark O'Loughlin, et al.
NPJ Breast Cancer|May 16, 2020
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working GroupMohamed Amgad, Elisabeth Specht Stovgaard, Eva Balslev, et al.
Pageof 2